Cover Feature: Synthesis of Thiazolidinedione- and Triazole-Linked Organoselenocyanates and Evaluation of Anticancer Activities Against Breast Cancer with Mechanistic Investigations (Chem. Eur. J. 11/2025)
Nikita Pal, Kaustav Banerjee, Shilpi Sarkar, Tapas K. Mandal, Krishna P. Bhabak
{"title":"Cover Feature: Synthesis of Thiazolidinedione- and Triazole-Linked Organoselenocyanates and Evaluation of Anticancer Activities Against Breast Cancer with Mechanistic Investigations (Chem. Eur. J. 11/2025)","authors":"Nikita Pal, Kaustav Banerjee, Shilpi Sarkar, Tapas K. Mandal, Krishna P. Bhabak","doi":"10.1002/chem.202581102","DOIUrl":null,"url":null,"abstract":"<p><b>Thiazolidinedione- and triazole-fused organoselenocyanates</b> have been developed towards the treatment of the most aggressive triple-negative breast cancer in females. Among the synthesized selenocyanates, the unsubstituted benzylic analogue of thiazolidinedione-based organoselenocyanate was the most potent exhibiting its anticancer activity by arresting cells in the G1 phase of the cell cycle with the downregulation of CDK4 and cyclin D1 and via the ERK/Akt signalling pathway. More information can be found in the Research Article by K. P. Bhabak and co-workers (DOI: 10.1002/chem.202403026).\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure>\n </p>","PeriodicalId":144,"journal":{"name":"Chemistry - A European Journal","volume":"31 11","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/chem.202581102","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemistry - A European Journal","FirstCategoryId":"92","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/chem.202581102","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Thiazolidinedione- and triazole-fused organoselenocyanates have been developed towards the treatment of the most aggressive triple-negative breast cancer in females. Among the synthesized selenocyanates, the unsubstituted benzylic analogue of thiazolidinedione-based organoselenocyanate was the most potent exhibiting its anticancer activity by arresting cells in the G1 phase of the cell cycle with the downregulation of CDK4 and cyclin D1 and via the ERK/Akt signalling pathway. More information can be found in the Research Article by K. P. Bhabak and co-workers (DOI: 10.1002/chem.202403026).
期刊介绍：
Chemistry—A European Journal is a truly international journal with top quality contributions (2018 ISI Impact Factor: 5.16). It publishes a wide range of outstanding Reviews, Minireviews, Concepts, Full Papers, and Communications from all areas of chemistry and related fields.
Based in Europe Chemistry—A European Journal provides an excellent platform for increasing the visibility of European chemistry as well as for featuring the best research from authors from around the world.
All manuscripts are peer-reviewed, and electronic processing ensures accurate reproduction of text and data, plus short publication times.
The Concepts section provides nonspecialist readers with a useful conceptual guide to unfamiliar areas and experts with new angles on familiar problems.
Chemistry—A European Journal is published on behalf of ChemPubSoc Europe, a group of 16 national chemical societies from within Europe, and supported by the Asian Chemical Editorial Societies. The ChemPubSoc Europe family comprises: Angewandte Chemie, Chemistry—A European Journal, European Journal of Organic Chemistry, European Journal of Inorganic Chemistry, ChemPhysChem, ChemBioChem, ChemMedChem, ChemCatChem, ChemSusChem, ChemPlusChem, ChemElectroChem, and ChemistryOpen.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
